Article Details

Innovent Biologics approaches USD 422 mln at Hong Kong IPO

Retrieved on: 2018-10-14 15:30:00

Tags for this article:

Click the tags to see associated articles and topics

Innovent Biologics approaches USD 422 mln at Hong Kong IPO. View article details on hiswai:

Excerpt

<div>Investors such as <b>Sequoia Capital</b> China, Shanghai-based Greenwoods Investment, Temasek Holdings Private Limited, Hong Kong-based asset ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo